Gazi et al \[[@B1]\] presented results of evaluation the accuracy of various formulas for the calculation of low-density lipoprotein cholesterol (LDL-C) levels -- indirect methods -- in patients with the metabolic syndrome. LDL-C according Friedewald\'s formula showed significant differences from other formulas in the total cohort, as well as in patients with metabolic syndrome. Different plasma lipid and lipoprotein analytical techniques -- direct methods, however, yield results, which are highly correlated, yet significantly different, too \[[@B2]\].

It is possible to supplement next calculation. Anandaraja et al \[[@B3]\] published new formula for LDL-C estimation from two other parameters, total cholesterol and triglycerides, as substitution to well known Friedewald\'s formula.

Our team recently compared two methods of estimation of low-density lipoprotein cholesterol, the direct Wako method versus Friedewald\'s formula \[[@B4]\]. We studied over 10 000 consecutive patients with different diseases, from mixed rural and urban Brazil population.

We re-counted our data with Anandaraja\'s formula. Main results are expressed in Table [1](#T1){ref-type="table"}. Direct LDL-C and LDL-C calculated from Anandaraja\'s formula shows substantial better correlation in both total population (r = 0,969) and patients with triglyceride \<350 mg/dl (r = 0,974) by comparison with calculated according to the Friedewald\'s formula (r = 0,924 and r = 0,935).

###### 

Low-density lipoprotein cholesterol level

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Particulars                                                                                                                       Total population         Patients with triglycerides\
                                                                                                                                                             \<350 mg/dl (3,94 mmol/l)
  --------------------------------------------------------------------------------------------------------------------------------- ------------------------ ------------------------------
  Total sample number                                                                                                               10 324                   10 102

  Direct low-density lipoprotein cholesterol (mg/dl; mmol/l)                                                                        116 ± 22 (2,99 ± 0,57)   115 ± 22 (2,97 ± 0,57)

  Calculated low-density lipoprotein cholesterol (mg/dl; mmol/l)\*                                                                  120 ± 24 (3,10 ± 0,62)   119 ± 23 (3,08 ± 0,59)

  Calculated low-density lipoprotein cholesterol (mg/dl; mmol/l)†                                                                   115 ± 23 (2,97 ± 0,59)   114 ± 21 (2,95 ± 0,54)

  Difference between direct low-density lipoprotein cholesterol and calculated low-density lipoprotein cholesterol (mg/dl)\*        \- 4 ± 16                \- 4 ± 14

  Difference between direct low-density lipoprotein cholesterol and calculated low-density lipoprotein cholesterol (mg/dl) †        1 ± 14                   1 ± 14

  Correlation coefficient between direct low-density lipoprotein cholesterol and calculated low-density lipoprotein cholesterol\*   0,924                    0,935

  Correlation coefficient between direct low-density lipoprotein cholesterol and calculated low-density lipoprotein cholesterol†    0,969                    0,974
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

All measurements are expressed in mg/dl (mmol/l) and results are presented as mean ± S.D. Pearson\'s correlation coefficient used. Direct LDL-C measured with Wako method -- for details see Ref. \[4\].

\* Calculated low-density lipoprotein cholesterol from Friedewald\'s formula

† Calculated low-density lipoprotein cholesterol from new Anandaraja\'s equation

In each very low-density lipoprotein particle secreted from the liver, and therefore in each intermediate-density lipoprotein, low-density lipoprotein and lipoprotein (a) particles, a single molecule of apolipoprotein B (apo B) is present from the time of its assembly to its catabolism, which does not exchange between lipoproteins. More than 90% of apo B is in the low-density lipoprotein particles, and therefore, plasma total concentration of apo B can be considered as a measure of the number of atherogenic particles. New Anandaraja\'s equation takes into account only total cholesterol and triglycerides. Some authors recommend including apo B measurement as acomponent of the standard lipoprotein measurements performed to assess cardiovascular disease risk \[[@B5]\]. Contribution of LDL-C calculation with help of measured apo B is questionable. Apo B is real an independent risk factor.

In conclusion, LDL-C is the major indicator for initial classification of coronary heart disease risk status and lowering its level is a primary goal of therapy. The NCEP Working Group on Lipoprotein Measurement recommended the development of accurate direct low-density lipoprotein cholesterol methods. All available direct methods have yet limitations for general use. Our results support the reliability of Anandaraja\'s formula as indirect low-density lipoprotein cholesterol estimation -- originally used in Indian population -- in Brazil population, too.
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